Legislation

Prohibiting a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential generic drug; requiring the Maryland Medical Assistance Program to notify the manufacturer of an essential generic drug and the Attorney General of a specified increase in the price of the essential generic drug under specified circumstances; requiring a manufacturer of an essential generic drug to submit a specified statement to the Attorney General within 20 days after receipt of a specified notice; etc.

Committees

Original:: Finance Click to view Recorded Media

Details

Cross-filed with: HB0631

Bill File Type: Regular

Effective Date(s): October 1, 2017

History

Legislation History
Chamber Senate Calendar Date 1/27/2017 Legislative Date 1/27/2017 Action First Reading Finance Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Public Health - Essential Generic Drugs - Price Gouging - Prohibition Proceedings
Chamber Senate Calendar Date 1/30/2017 Legislative Date 1/30/2017 Action Hearing 2/15 at 1:00 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
Senate	1/27/2017	1/27/2017	First Reading Finance
			Text - First - Public Health - Essential Generic Drugs - Price Gouging - Prohibition
Senate	1/30/2017	1/30/2017	Hearing 2/15 at 1:00 p.m.

File Code

Subjects

Statutes